DERMIRA INC's ticker is DERM and the CUSIP is 24983L104. A total of 127 filers reported holding DERMIRA INC in Q3 2017. The put-call ratio across all filers is 1.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $277,000 | -80.5% | 10,256 | -79.0% | 0.05% | -84.5% |
Q2 2017 | $1,423,000 | +64.1% | 48,842 | +92.1% | 0.30% | +82.7% |
Q1 2017 | $867,000 | +99.8% | 25,431 | +77.6% | 0.16% | +63.6% |
Q4 2016 | $434,000 | -33.7% | 14,320 | -26.0% | 0.10% | -30.3% |
Q3 2016 | $655,000 | +112.0% | 19,359 | +83.3% | 0.14% | +19.3% |
Q2 2016 | $309,000 | – | 10,560 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ORACLE INVESTMENT MANAGEMENT INC | 1,760,072 | $16,826,000 | 3.62% |
NEA Management Company, LLC | 3,506,649 | $33,524,000 | 2.35% |
GREAT POINT PARTNERS LLC | 1,552,900 | $14,846,000,000 | 1.65% |
APIS CAPITAL ADVISORS, LLC | 100,000 | $956,000 | 1.43% |
NEXTHERA CAPITAL LP | 138,102 | $1,320,000 | 1.10% |
Eversept Partners, LP | 399,874 | $3,822,795 | 1.07% |
Jeneq Management LP | 96,570 | $923,000 | 0.82% |
Trellus Management Company, LLC | 60,000 | $574,000 | 0.78% |
PFM Health Sciences, LP | 4,044,542 | $38,666,000 | 0.73% |
Birchview Capital, LP | 120,000 | $1,147,000 | 0.70% |